West Oak Capital’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-400
Closed -$40K 322
2019
Q3
$40K Hold
400
0.02% 187
2019
Q2
$37K Hold
400
0.02% 198
2019
Q1
$38K Hold
400
0.02% 187
2018
Q4
$25.6K Hold
400
0.02% 196
2018
Q3
$35.8K Hold
400
0.02% 198
2018
Q2
$31.8K Hold
400
0.02% 197
2018
Q1
$35.7K Hold
400
0.02% 201
2017
Q4
$41.7K Hold
400
0.03% 178
2017
Q3
$58.3K Hold
400
0.03% 176
2017
Q2
$51.9K Hold
400
0.03% 184
2017
Q1
$49.8K Hold
400
0.03% 186
2016
Q4
$46.3K Hold
400
0.03% 187
2016
Q3
$41.8K Hold
400
0.03% 193
2016
Q2
$39.5K Hold
400
0.03% 177
2016
Q1
$40K Hold
400
0.03% 155
2015
Q4
$47.9K Hold
400
0.04% 152
2015
Q3
$43.3K Hold
400
0.03% 157
2015
Q2
$46.3K Hold
400
0.03% 153
2015
Q1
$46.1K Hold
400
0.03% 153
2014
Q4
$44.7K Hold
400
0.03% 153
2014
Q3
$37.9K Hold
400
0.03% 151
2014
Q2
$34.4K Hold
400
0.02% 157
2014
Q1
$27.9K Hold
400
0.02% 169
2013
Q4
$33.8K Hold
400
0.02% 161
2013
Q3
$30.8K Hold
400
0.02% 162
2013
Q2
$23.4K Buy
+400
New +$24.1K 0.02% 168

Other funds holding CELG

West Oak Capital's CELG Position: Q4 2019 in Review

West Oak Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 400 shares — an estimated $40K sold.

West Oak Capital first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $58.3K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • West Oak Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • West Oak Capital sold 400 Celgene Corp shares in Q4 2019, an estimated $40K.
  • West Oak Capital first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • West Oak Capital's Celgene Corp position peaked at $58.3K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on West Oak Capital's 13F filing for Q4 2019, filed 9 Jan 2020.